Aggregate content influences the Thl/Th2 immune response to influenza vaccine: Evidence from a mouse model

被引:31
作者
Babiuk, S
Skowronski, DM
De Serres, G
HayGlass, K
Brunham, RC
Babiuk, L [1 ]
机构
[1] Vaccine & Infect Dis Org, Saskatoon, SK S7N 5E3, Canada
[2] UBC Ctr Dis Control, Epidemiol Serv, Vancouver, BC, Canada
[3] Inst Natl Sante Publ Quebec, Quebec City, PQ, Canada
[4] Univ Manitoba, Dept Immunol, Canada Res Chair Immune Regulat, Winnipeg, MB, Canada
关键词
ORS; Th2; response; IL-4; IFN-gamma; mice; vaccine formulation;
D O I
10.1002/jmv.10540
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
During the 2000-2001 season, a newly identified oculo-respiratory syndrome (ORS) was detected across Canada as an adverse effect to one influenza vaccine. The implicated vaccine contained a higher than expected proportion of unsplit and aggregated influenza virions. Clinical and epidemiologic features of ORS were suggestive of type 2-like influences on the immune response. We hypothesized that the implicated vaccine from the 2000-2001 season would induce greater Th2-like polarization relative to the non-implicated vaccine from the same season. Three groups consisting of eight mice each were either immunized with implicated vaccine, immunized with non-implicated vaccine or not immunized. Antigen-specific cellular responses were characterized based on the balance of Th2 (IL-4, IL-5) and Th1 (IFN-gamma) cytokines in vitro. We confirm that vaccine aggregates deviate the immune response to a greater Th2 cytokine pattern with potential implications for vaccine screening, safety, and efficacy.
引用
收藏
页码:138 / 142
页数:5
相关论文
共 15 条
[11]   Immunopathogenesis of vaccine-enhanced RSV disease [J].
Openshaw, PJM ;
Culley, FJ ;
Olszewska, W .
VACCINE, 2001, 20 :S27-S31
[12]   Oculo-respiratory syndrome: A new influenza vaccine-associated adverse event? [J].
Skowronski, DM ;
Strauss, B ;
De Serres, G ;
MacDonald, D ;
Marion, SA ;
Naus, M ;
Patrick, DM ;
Kendall, P .
CLINICAL INFECTIOUS DISEASES, 2003, 36 (06) :705-713
[13]   Does antigen-specific cytokine response correlate with the experience of oculorespiratory syndrome after influenza vaccine? [J].
Skowronski, DM ;
Lu, H ;
Warrington, R ;
Hegele, RG ;
De Serres, G ;
HayGlass, K ;
Stark, D ;
White, R ;
Macnabb, J ;
Li, Y ;
Manson, HE ;
Brunham, RC .
JOURNAL OF INFECTIOUS DISEASES, 2003, 187 (03) :495-499
[14]   Skin testing to evaluate oculo-respiratory syndrome (ORS) associated with influenza vaccination during the 2000-2001 season [J].
Skowronski, DM ;
De Serres, G ;
Hebert, J ;
Stark, D ;
Warrington, R ;
Macnabb, J ;
Shadmani, R ;
Rochette, L ;
MacDonald, D ;
Patrick, DM ;
Duval, B .
VACCINE, 2002, 20 (21-22) :2713-2719
[15]   Type 1 type 2 immunity in infectious diseases [J].
Spellberg, B ;
Edwards, JE .
CLINICAL INFECTIOUS DISEASES, 2001, 32 (01) :76-102